Jane Street
AIM

Jane Street’s AIM ImmunoTech AIM Stock Holding History

Jane Street’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$229K Buy
807,885
+787,838
+3,930% +$360K ﹤0.01% 9798
2026
Q1 		$11.7K Buy
+20,047
New +$20.3K ﹤0.01% 11288
2024
Q1 		– Sell
-213
Closed -$9.35K – 10472
2023
Q4 		$9.35K Buy
213
+76
+55% +$3.54K ﹤0.01% 8969
2023
Q3 		$6.23K Sell
137
-85
-38% -$5.24K ﹤0.01% 8428
2023
Q2 		$14.8K Buy
+222
New +$10.7K ﹤0.01% 8391
2022
Q3 		– Sell
-104
Closed -$8K – 11015
2022
Q2 		$8K Buy
+104
New +$9.98K ﹤0.01% 9363
2022
Q1 		– Sell
-155
Closed -$14K – 11590
2021
Q4 		$14K Buy
+155
New +$24K ﹤0.01% 9869
2020
Q2 		– Sell
-281
Closed -$72K – 7887
2020
Q1 		$72K Buy
+281
New +$44.1K ﹤0.01% 5028

Other funds holding AIM

VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
CA
Continuum Advisory Eagle, Idaho $1.24B AUM 30.12% 1-Year Est. Return

Jane Street's AIM Position: Q2 2026 in Review

Jane Street increased its AIM ImmunoTech (AIM) stake by 3,930% in Q2 2026, buying an estimated $360K and bringing the position to 807,885 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #9798.

Jane Street first reported a position in AIM in Q1 2020 and has held it in 8 quarters since. 18 funds tracked by Wall St. Rank hold AIM as of Q2 2026.

  • Jane Street held 807,885 shares of AIM ImmunoTech worth $229K as of Q2 2026.
  • Jane Street bought 787,838 AIM ImmunoTech shares in Q2 2026, an estimated $360K.
  • AIM ImmunoTech made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #9798 holding.
  • Jane Street first reported a position in AIM ImmunoTech in Q1 2020 and has held it in 8 quarters since.
  • 18 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.